PREVIOUS
✖
GLP-1 receptor agonists
February 25 , 2025
4 hrs 0 min
21
0
- Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are novel drugs approved for diabetes and obesity.
- They are originally developed for treating diabetes, work by stimulating insulin secretion and suppressing glucagon release, thereby helping regulate blood sugar.
- Now, these drugs also act on the brain’s reward system, an area deeply involved in addiction.
Leave a Reply
Your Comment is awaiting moderation.